Correction: Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells (Journal of Nanobiotechnology, (2022), 20, 1, (546), 10.1186/s12951-022-01749-3)

Yanyu Chen, Zhuhao Wu, Joseph Sutlive, Ke Wu, Lu Mao, Jiabao Nie, Xing Zhong Zhao, Feng Guo, Zi Chen, Qinqin Huang

Research output: Contribution to journalComment/debate

Abstract

Following publication of the original article [1], the authors would like to correct the affiliations of all the authors. The revised affiliations are provided below. 1. The Research and Application Center of Precision Medicine, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450052, China 2. School of Physics and Technology, Wuhan University, Wuhan 430072, China 3. Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN 47405, USA 4. Division of Thoracic and Cardiac Surgery, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA 5. Department of Biological Sciences, Northeastern University, Boston, MA 02115, USA The original article has been corrected.

Original languageEnglish
Article number67
JournalJournal of Nanobiotechnology
Volume21
Issue number1
DOIs
StatePublished - Dec 2023
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction: Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells (Journal of Nanobiotechnology, (2022), 20, 1, (546), 10.1186/s12951-022-01749-3)'. Together they form a unique fingerprint.

Cite this